Semustine

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC, NSABP Foundation Inc, The First Affiliated Hospital of Soochow University

Conditions

AstrocytomaColorectal CancerEngraft FailureGVHDGlioblastomaRelapse

Phase 3

Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)

CompletedNCT00335075

Merck Sharp & Dohme LLCAstrocytoma, Glioblastoma

Start: 2005-03-02End: 2006-02-23Updated: 2017-05-15

Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery

CompletedNCT00427570

NSABP Foundation IncColorectal Cancer

Start: 1977-09-30End: 2006-05-31Updated: 2013-06-24

Outcomes of Patients After Allo-HSCT With Decitabine and NAC

The First Affiliated Hospital of Soochow UniversityEngraft Failure, GVHD, Relapse

Start: 2021-07-01End: 2025-12-01Target: 100Updated: 2021-06-30